These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38482580)

  • 21. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial.
    Praga M; Barrio V; Juárez GF; Luño J;
    Kidney Int; 2007 May; 71(9):924-30. PubMed ID: 17377504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Exploration of Mahuang Fuzi Xixin Decoction formula syndromes based on severe cases of critical care and its application for nosocomial infection in critical care medicine including hyperpyrexia after tracheotomy and severe pain accompanied by acute myocardial infarction and diabetic peripheral neuropathy].
    Xiong XJ
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(18):3869-3875. PubMed ID: 31872717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
    Guo Y; Wu X; Liu L; Zhang H; Yang L; Chen W
    Ren Fail; 2020 Nov; 42(1):122-130. PubMed ID: 31957527
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversal of endothelial dysfunction post-immunosuppressive therapy in adult-onset podocytopathy and primary membranous nephropathy.
    Inamdar N; Tomer S; Kalmath S; Bansal A; Yadav AK; Sharma V; Bahuguna P; Gorsi U; Arora S; Lal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Ramachandran R
    Atherosclerosis; 2020 Feb; 295():38-44. PubMed ID: 32004823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.
    Hoxha E; Thiele I; Zahner G; Panzer U; Harendza S; Stahl RA
    J Am Soc Nephrol; 2014 Jun; 25(6):1357-66. PubMed ID: 24610926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM; Branten AJ; Wirtz JJ; Noordzij TC; du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
    Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
    Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
    Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary membranous nephropathy in adolescence: A prospective study.
    Kumar V; Varma AK; Nada R; Ghosh R; Suri D; Gupta A; Kumar V; Rathi M; Kohli H; Jha V; Gupta K; Ramachandran R
    Nephrology (Carlton); 2017 Sep; 22(9):678-683. PubMed ID: 27334445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
    Shibasaki T; Koyama A; Hishida A; Muso E; Osawa G; Yamabe H; Shiiki H; Makino H; Sato H; Ishikawa I; Maeda K; Tomita K; Arakawa M; Ishida M; Sato M; Nagase M; Kashihara N; Yorioka N; Koike T; Saito T; Harada T; Mitarai T; Sugisaki T; Nagasawa T; Tomino Y; Nojima Y; Kobayashi Y; Sakai O
    Clin Exp Nephrol; 2004 Jun; 8(2):117-26. PubMed ID: 15235928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness.
    Bazzi C; Rizza V; Casellato D; Tofik R; Berg AL; Gallieni M; D'Amico G; Bakoush O
    BMC Nephrol; 2014 May; 15():74. PubMed ID: 24886340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A novel approach to rapid induction of remission in primary membranous nephropathy].
    Dobronravov VA; Bystrova OB; Kochoyan ZS; Fomicheva EN
    Ter Arkh; 2021 Jun; 93(6):706-712. PubMed ID: 36286838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
    Chen M; Li H; Li XY; Lu FM; Ni ZH; Xu FF; Li XW; Chen JH; Wang HY;
    Am J Med Sci; 2010 Mar; 339(3):233-8. PubMed ID: 20220333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.
    Teisseyre M; Cremoni M; Boyer-Suavet S; Ruetsch C; Graça D; Esnault VLM; Brglez V; Seitz-Polski B
    Front Immunol; 2022; 13():859419. PubMed ID: 35603210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the efficacy and safety of tacrolimus monotherapy and cyclophosphamide combined with glucocorticoid in the treatment of adult primary membranous nephropathy: protocol of a multicenter, randomized, controlled, open study.
    Chen S; Ren S; Wang AY; Tran H; Li Z; Cheng X; Liu M; Li G; Wang L; Hong D
    Trials; 2020 Feb; 21(1):219. PubMed ID: 32093742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial.
    Chen W; Liu Q; Liao Y; Yang Z; Chen J; Fu J; Zhang J; Kong Y; Fu P; Lou T; Liu Z; Ji Y; Li Z; Yu X
    Am J Med Sci; 2013 Feb; 345(2):81-7. PubMed ID: 22627258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive Therapy in Primary Membranous Nephropathy with Compromised Renal Function.
    Ramachandran R; Prabakaran R; Priya G; Nayak S; Kumar P; Kumar A; Kumar V; Agrawal N; Rathi M; Kohli HS; Nada R
    Nephron; 2022; 146(2):138-145. PubMed ID: 34818240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.